Related Experiment Videos

Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors

N F Ford, L J Browne, T Campbell

Journal of Medicinal Chemistry

|February 1, 1985

Abstract:

The synthesis and structure-activity profile of a new class of potent and highly specific thromboxane A2 synthetase inhibitors is described. The most potent member of this series in vitro is determined to be imidazo[1,5-a]-pyridine-5-hexanoic acid (9).

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Complications during repeated tracheal intubation in the Intensive Care Unit. A prospective, observational study comparing the first intubation and the reintubation.

Revista espanola de anestesiologia y reanimacion·2021

Oral theophylline for chronic obstructive pulmonary disease.

The Cochrane database of systematic reviews·2003

Congenital diaphragmatic hernia and hydrops: a lethal association?

Journal of pediatric surgery·2002

Nitric oxide donors induce large-scale deletion mutations in human lymphoblastoid cells: implications for mutations in T-lymphocytes from arthritis patients.

Environmental and molecular mutagenesis·2002

Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design.

Journal of medicinal chemistry·2001

6-(4-Benzylpiperazin-1-yl)benzodioxanes as selective ligands at cloned primate dopamine D(4) receptors.

Bioorganic & medicinal chemistry·2001

See all related articles